title: A review of denosumab for the treatment of osteoporosis.
abstract: Osteoporosis is an age-related systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility. Bone remodeling involves two types of cells: osteoblasts and osteoclasts. Receptor activator of nuclear factor-κB ligand (RANKL) is a key regulator of the formation and function of bone-resorbing osteoclasts, and its cell surface receptor, receptor activator of nuclear factor-κB (RANK), is expressed by both osteoclast precursors and mature osteoclasts. Denosumab is a fully human monoclonal anti-RANKL antibody that inhibits the binding of RANKL to RANK, thereby decreasing osteoclastogenesis and bone-resorbing activity of mature osteoclasts. Although there are many medications available for the treatment of osteoporosis, inhibition of RANKL by denosumab has been shown to significantly affect bone metabolism. Denosumab appears to be a promising, highly effective, and safe parenteral therapy with good adherence for osteoporosis. Moreover, denosumab may be cost-effective therapy compared with existing alternatives. Therefore, in this review, we focus on studies of denosumab and the risks and benefits identified for this type of treatment for osteoporosis.
authors.affiliation: Department of Orthopedic Surgery, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku, Tokyo, Japan ; Department of Geriatric Medicine, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku, Tokyo, Japan.
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Miyazaki
authors.affiliation: Department of Orthopedic Surgery, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku, Tokyo, Japan.
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Tokimura
authors.affiliation: Department of Orthopedic Surgery, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
authors.forename: Sakae
authors.initials: S
authors.lastname: Tanaka
keywords: OPG; RANKL; bone resorption; osteoclast
references.citation: J Cell Biochem. 1994 Jul;55(3):273-86
references.pmid: 7962158
references.citation: J Bone Miner Res. 2004 Jul;19(7):1059-66
references.pmid: 15176987
references.citation: Osteoporos Int. 2005 Feb;16(2):149-54
references.pmid: 15185066
references.citation: Arthritis Res Ther. 2006;8(5):219
references.pmid: 17049069
references.citation: Nat Med. 2011 Sep 11;17(10):1231-4
references.pmid: 21909105
references.citation: Immunity. 2003 Dec;19(6):849-61
references.pmid: 14670302
references.citation: Endocrinology. 1988 Apr;122(4):1373-82
references.pmid: 3345718
references.citation: J Biol Chem. 2006 Dec 1;281(48):36846-55
references.pmid: 17018528
references.citation: Nature. 1999 Jan 28;397(6717):315-23
references.pmid: 9950424
references.citation: J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65
references.pmid: 20173017
references.citation: Genes Dev. 1998 May 1;12(9):1260-8
references.pmid: 9573043
references.citation: Cell. 1997 Apr 18;89(2):309-19
references.pmid: 9108485
references.citation: Appl Health Econ Health Policy. 2013 Oct;11(5):485-97
references.pmid: 23868102
references.citation: J Med Econ. 2012;15 Suppl 1:3-14
references.pmid: 23035625
references.citation: J Bone Miner Res. 2011 Nov;26(11):2737-44
references.pmid: 21735475
references.citation: J Clin Endocrinol Metab. 2011 Apr;96(4):972-80
references.pmid: 21289258
references.citation: Nat Rev Immunol. 2007 Apr;7(4):292-304
references.pmid: 17380158
references.citation: Bone. 2011 Aug;49(2):151-61
references.pmid: 21457806
references.citation: Bone. 2010 Jul;47(1):34-40
references.pmid: 20303422
references.citation: Endocrinology. 1999 Oct;140(10):4382-9
references.pmid: 10499489
references.citation: J Bone Miner Res. 2010 Oct;25(10):2256-65
references.pmid: 20533525
references.citation: Osteoporos Int. 1997;7(5):407-13
references.pmid: 9425497
references.citation: J Biol Chem. 2001 May 4;276(18):14665-74
references.pmid: 11278735
references.citation: Nat Med. 2013 Mar;19(3):358-63
references.pmid: 23396210
references.citation: J Bone Miner Res. 2007 Feb;22(2):203-10
references.pmid: 17059370
references.citation: J Clin Endocrinol Metab. 2004 Oct;89(10):4879-85
references.pmid: 15472179
references.citation: Lancet. 2013 Jul 6;382(9886):50-6
references.pmid: 23683600
references.citation: J Bone Miner Res. 2012 Mar;27(3):694-701
references.pmid: 22113951
references.citation: Nature. 1997 Nov 13;390(6656):175-9
references.pmid: 9367155
references.citation: N Engl J Med. 2006 Feb 23;354(8):821-31
references.pmid: 16495394
references.citation: Osteoporos Int. 2013 Jan;24(1):227-35
references.pmid: 22776860
references.citation: Mayo Clin Proc. 2005 Jul;80(7):856-61
references.pmid: 16007889
references.citation: Am J Kidney Dis. 2010 Feb;55(2):291-9
references.pmid: 20042259
references.citation: Curr Osteoporos Rep. 2012 Mar;10(1):64-72
references.pmid: 22234741
references.citation: JAMA. 1995 Dec 6;274(21):1683-6
references.pmid: 7474272
references.citation: Biochem Biophys Res Commun. 2000 Sep 7;275(3):768-75
references.pmid: 10973797
references.citation: N Engl J Med. 2009 Aug 20;361(8):756-65
references.pmid: 19671655
references.citation: Cell. 1998 Apr 17;93(2):165-76
references.pmid: 9568710
references.citation: Endocr Rev. 1986 Nov;7(4):379-408
references.pmid: 3536460
references.citation: Bone. 2011 Nov;49(5):1101-7
references.pmid: 21871589
references.citation: Ther Adv Musculoskelet Dis. 2011 Dec;3(6):271-82
references.pmid: 22870485
references.citation: N Engl J Med. 1997 Dec 4;337(23):1641-7
references.pmid: 9385122
references.citation: Osteoporos Int. 2008 Nov;19(11):1549-56
references.pmid: 18392664
references.citation: Dev Cell. 2002 Apr;2(4):389-406
references.pmid: 11970890
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(18):7260-4
references.pmid: 2169622
references.citation: Nature. 1999 Nov 18;402(6759):304-9
references.pmid: 10580503
references.citation: J Immunol. 2012 Dec 15;189(12):5519-26
references.pmid: 23152561
references.citation: Osteoporos Int. 2013 Jan;24(1):209-17
references.pmid: 22832638
references.citation: Arthritis Res Ther. 2007;9 Suppl 1:S3
references.pmid: 17634142
references.citation: JAMA. 1996 Nov 6;276(17):1389-96
references.pmid: 8892713
references.citation: J Biochem. 2013 Jul;154(1):29-39
references.pmid: 23750028
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602
references.pmid: 9520411
references.citation: J Biol Chem. 1997 Oct 3;272(40):25190-4
references.pmid: 9312132
references.citation: Endocr Rev. 1992 Feb;13(1):66-80
references.pmid: 1555533
references.citation: Calcif Tissue Int. 2003 Nov;73(5):423-32
references.pmid: 12964065
references.citation: J Bone Miner Res. 2012 Jul;27(7):1471-9
references.pmid: 22461041
references.citation: Osteoporos Int. 2012 Jan;23(1):317-26
references.pmid: 21927922
references.citation: Blood. 2000 Dec 15;96(13):4335-43
references.pmid: 11110710
references.citation: Endocrinology. 1999 Sep;140(9):4367-70
references.pmid: 10465311
references.citation: Clin Immunol. 2003 Dec;109(3):347-54
references.pmid: 14697750
references.citation: J Biol Chem. 2001 Jun 8;276(23):20659-72
references.pmid: 11274143
references.citation: Endocrinology. 1989 Oct;125(4):1805-13
references.pmid: 2676473
references.citation: Semin Arthritis Rheum. 2011 Oct;41(2):178-86
references.pmid: 21616520
references.citation: J Bone Miner Res. 2011 Jan;26(1):19-26
references.pmid: 20593411
references.citation: Osteoporos Int. 2010 Nov;21(11):1963-4
references.pmid: 20012939
references.citation: J Exp Med. 1999 Apr 5;189(7):1025-31
references.pmid: 10190893
references.citation: J Cell Biochem. 2003 May 1;89(1):180-90
references.pmid: 12682918
references.citation: Pharmacoeconomics. 2011 Oct;29(10):895-911
references.pmid: 21692551
references.citation: Gut. 2005 Apr;54(4):479-87
references.pmid: 15753532
references.citation: J Bone Miner Res. 2001 Feb;16(2):348-60
references.pmid: 11204435
references.citation: Osteoporos Int. 2004 Dec;15(12):1003-8
references.pmid: 15167989
references.citation: Osteoporos Int. 2004 Mar;15(3):175-9
references.pmid: 14691617
references.citation: Osteoporos Int. 2012 Mar;23(3):1131-40
references.pmid: 21927920
references.citation: J Bone Miner Res. 2007 Dec;22(12):1832-41
references.pmid: 17708711
references.citation: Osteoporos Int. 2011 Mar;22(3):967-82
references.pmid: 20936401
references.citation: Ann Intern Med. 2006 May 16;144(10):753-61
references.pmid: 16702591
references.citation: Bone. 2006 Oct;39(4):872-9
references.pmid: 16765660
references.citation: Bone. 2008 Aug;43(2):222-9
references.pmid: 18539106
references.citation: Lancet. 2002 Jun 8;359(9322):2018-26
references.pmid: 12076571
references.citation: J Bone Miner Res. 2009 Feb;24(2):182-95
references.pmid: 19016581
references.citation: Endocr Rev. 2001 Aug;22(4):477-501
references.pmid: 11493580
references.citation: Endocr Rev. 1999 Jun;20(3):345-57
references.pmid: 10368775
references.citation: J Bone Miner Res. 2012 Jan;27(1):211-8
references.pmid: 21976367